NOV 15, 2018 10:00 AM PST

Multiplex fluorescence immunohistochemistry using the Ultivue InSituPlex platform on the Leica Biosystems BOND RX

Sponsored by: Leica Biosystems
Speakers

Abstract
DATE: November 15, 2018
TIME: 10:00am PST, 1:00pm EST
 
Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the analysis of target protein expression in subsets of specific cells within the context of histopathological features of disease. However, the multiplexing capabilities of fluorescence IHC, using standard histology equipment, are subject to several technical challenges. This webinar will provide insight and examples of how the Ultivue InSituplex platform may be used to address several of the current challenges associated with multiplex fluorescence immunohistochemistry. It will focus on initial user experiences using the InSituPlex platform using automated IHC on the Leica Biosystems BOND RX and automated imaging with the Leica Biosystems Aperio Versa.
 
Learning Objective:
  • Understanding technical challenges associated with tyramide-based multiplex fluorescence IHC.
  • What tools are available today for mulitplex?
 
*For research use only. Not for use in diagnostic procedures.

Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
APR 21, 2021 5:00 PM CEST
APR 21, 2021 5:00 PM CEST
Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
NOV 15, 2018 10:00 AM PST

Multiplex fluorescence immunohistochemistry using the Ultivue InSituPlex platform on the Leica Biosystems BOND RX

Sponsored by: Leica Biosystems

Specialty

Cancer Research

Molecular Biology

Biotechnology

Cell Biology

Immunology

Biomarkers

Cancer Diagnostics

Clinical Research

Molecular Diagnostics

Laboratory Testing

Clinical Diagnostics

Assay Development

Genetics

Diagnostics

Pathology

Geography

North America61%

Europe20%

Asia13%

South America3%

Oceania2%

Africa1%

Registration Source

Website Visitors70%

Email Promotions22%

WAVE Newsletter Promotion2%

Social Media Promotions1%

Trending Newsletter Promotion1%

Other3%

Job Title

Medical Laboratory Technician16%

Scientist15%

Facility/Department Manager14%

Research Scientist14%

Executive10%

Student7%

Post Doc4%

Medical Doctor/Specialist4%

Clinical Laboratory Scientist4%

Educator/Faculty4%

Lab Management3%

Marketing/Sales2%

Pathologist1%

Consultant1%

Engineer1%

Biologist1%

Organization

Academic Institution16%

Hospital15%

Biotech Company11%

Research Institute8%

Pharmaceutical Company7%

Clinical Laboratory7%

Life Science Company6%

Medical Device Company5%

Medical Center3%

Government3%

Contract Research Organization (Cro)3%

Medical School2%

Industrial Company2%

Distribution/sales1%

Other4%


Show Resources
Loading Comments...
Show Resources